LUPIN
Back to Income Statement
|
LUPIN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹3,282 Cr | ₹1,914 Cr | ₹430 Cr | ₹-1,528 Cr | ₹1,217 Cr |
What is the latest Consolidated Net Profit of LUPIN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹3,282 Cr |
| Mar2025 | ₹1,914 Cr |
| Mar2024 | ₹430 Cr |
| Mar2023 | ₹-1,528 Cr |
| Mar2022 | ₹1,217 Cr |
How is Consolidated Net Profit of LUPIN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,282 Cr | 71.41 | |
| Mar2025 | ₹1,914 Cr | 345.15 | |
| Mar2024 | ₹430 Cr | Positive | |
| Mar2023 | ₹-1,528 Cr | Negative | |
| Mar2022 | ₹1,217 Cr | - | |
Compare Consolidated Net Profit of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹88,990.6 Cr | -4.4% | -7% | 1.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -4.4% |
-7% |
1.1% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses